Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization: 2019-2024

Historic Accumulated Depreciation & Amortization for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $446,000.

  • Eton Pharmaceuticals' Accumulated Depreciation & Amortization rose 12.91% to $446,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year increase of 12.78%. This contributed to the annual value of $446,000 for FY2024, which is 12.91% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Accumulated Depreciation & Amortization of $446,000 as of Q4 2024, which was up 2.76% from $434,000 recorded in Q3 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $692,000 during Q4 2020, and registered a low of $13,000 during Q4 2022.
  • For the 3-year period, Eton Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $274,667, with its median value being $379,000 (2023).
  • Per our database at Business Quant, Eton Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 96.68% in 2021 and then surged by 2,938.46% in 2023.
  • Over the past 5 years, Eton Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $692,000 in 2020, then crashed by 96.68% to $23,000 in 2021, then plummeted by 43.48% to $13,000 in 2022, then spiked by 2,938.46% to $395,000 in 2023, then increased by 12.91% to $446,000 in 2024.
  • Its last three reported values are $446,000 in Q4 2024, $434,000 for Q3 2024, and $422,000 during Q2 2024.